Prospective Evaluation of Programmed Ventricular Stimulation Before Pulmonary Valve Replacement in Patients With Tetralogy of Fallot
1 other identifier
observational
100
1 country
1
Brief Summary
Severe pulmonary regurgitation is common in patients with Tetralogy of Fallot and results in progressive right ventricular dilatation and dysfunction. Pulmonary valve replacement is frequent in this population, and percutaneous procedures are increasing. Ventricular arrhythmias are a frequent late complication in patients with tetralogy of Fallot. The most common critical isthmus of ventricular tachycardias is between the pulmonary valve and the ventricular septal defect patch. While an electrophysiology study is sometimes performed in expert centers before surgical pulmonary valve replacement to guide a surgical ablation if needed, this approach is not recommended in current guidelines. An electrophysiology study should also be considered before percutaneous pulmonary valve replacement, as a part of the critical isthmus may be covered by the prosthetic pulmonary valve. Moreover, ablation after percutaneous pulmonary valve insertion exposes patients to the risks of traumatic valve or stent injury and infectious endocarditis. At present, reliable predictors to identify high-risk patients in whom an electrophysiology study should be performed before pulmonary valve replacement are lacking. The aim of this study is to assess prospectively the yield of systematic electrophysiology study and programmed ventricular stimulation before surgical and percutaneous pulmonary valve replacement in patients with tetralogy of Fallot.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2019
CompletedFirst Posted
Study publicly available on registry
December 19, 2019
CompletedStudy Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedMarch 9, 2021
March 1, 2021
2 years
December 15, 2019
March 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive programmed ventricular stimulation defined as inducibility of sustained ventricular tachycardia or fibrillation
Rate of sustained monomorphic or polymorphic ventricular tachycardia or ventricular fibrillation sustained \> 30 secondes during programmed ventricular stimulation
During ventricular programmed stimulation
Secondary Outcomes (3)
Critical isthmus involved in ventricular tachycardias induced
During ventricular programmed stimulation
Complications associated with programmed ventricular stimulation
1 month
Rate of ventricular arrhythmias during the follow-up after pulmonary valve replacement
24 months
Study Arms (1)
Programmed ventricular stimulation before PVR
Interventions
Programmed ventricular stimulation before pulmonary valve replacement. Voltage and activation mapping of right ventricle in a subset of patients.
Eligibility Criteria
All patients with repaired tetralogy of Fallot referred for surgical or percutaneous pulmonary valve replacement
You may qualify if:
- All patients with repaired tetralogy of Fallot referred for surgical or percutaneous pulmonary valve replacement
You may not qualify if:
- Absence of patient's consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Paris Cardiovascular Research Center (Inserm U970)lead
- European Georges Pompidou Hospitalcollaborator
- Centre Chirurgical Marie Lannelonguecollaborator
- Clinique Pasteur Toulousecollaborator
- Hopital Louis Pradelcollaborator
- Hôpital Necker-Enfants Maladescollaborator
Study Sites (1)
Paris Cardiovascular Research Center
Paris, 75015, France
Related Publications (1)
Waldmann V, Bessiere F, Gardey K, Bakloul M, Belli E, Bonnet D, Chaussade AS, Cohen S, Delasnerie H, Dib N, Di Filippo S, Dulac A, Hascoet S, Henaine R, Iserin L, Karsenty C, Ladouceur M, Legendre A, Malekzadeh-Milani S, Mostefa Kara M, Radojevic J, Ratsimandresy M, Marijon E, Maltret A, Khairy P, Combes N. Systematic Electrophysiological Study Prior to Pulmonary Valve Replacement in Tetralogy of Fallot: A Prospective Multicenter Study. Circ Arrhythm Electrophysiol. 2023 Jun;16(6):e011745. doi: 10.1161/CIRCEP.122.011745. Epub 2023 May 12.
PMID: 37170812DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Victor Waldmann, MD, MPH
European Georges Pompidou Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2019
First Posted
December 19, 2019
Study Start
January 1, 2020
Primary Completion
December 31, 2021
Study Completion
December 31, 2023
Last Updated
March 9, 2021
Record last verified: 2021-03